Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-004048

EVP, Research & CSO sold 10,530 shares at $38.00 ($400,140)

  • EVP, Research & CSO acquired 10,530 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-01-15 Option exercise +10,530 $1.53 $16,111 43,730 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-01-15 Sale −10,530 $38.00 $400,140 33,200 D: show line 2 in the form
Open-market sales · 10,530 sh · avg $38.00 · $400,140

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-01-15 Option exercise · Stock Option (Right to Buy) −10,530 411,455 D: show line 3 in the form
Loading xslF345X03/doc4.xml…